S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.34 (+1.09%)
MSFT   331.61 (-0.38%)
META   264.64 (+0.99%)
GOOGL   123.75 (-0.69%)
AMZN   121.30 (+0.99%)
TSLA   198.96 (+3.00%)
NVDA   403.34 (+3.56%)
NIO   7.37 (-4.29%)
BABA   78.59 (-2.94%)
AMD   126.05 (-0.77%)
T   15.64 (+0.90%)
F   12.65 (+4.63%)
MU   72.67 (-1.70%)
CGC   0.87 (-1.33%)
GE   102.03 (-0.69%)
DIS   87.47 (-0.93%)
AMC   4.56 (-1.72%)
PFE   37.08 (-1.38%)
PYPL   61.06 (+1.39%)
NFLX   391.62 (+3.36%)
NASDAQ:HCWB

HCW Biologics (HCWB) News Today

$1.56
-0.09 (-5.45%)
(As of 12:41 PM ET)
Compare
Today's Range
$1.55
▼
$1.64
50-Day Range
$1.29
▼
$1.65
52-Week Range
$1.08
▼
$2.79
Volume
10,051 shs
Average Volume
18,953 shs
Market Capitalization
$55.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
Get HCW Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter.



HCWB Media Mentions By Week

HCWB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCWB
News Sentiment
▼
1.09

0.78
▲
Average
Medical
News Sentiment

HCWB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCWB Articles
This Week
▼
6

1
▲
HCWB Articles
Average Week

SourceHeadline
MarketBeat logoRebecca Byam Acquires 20,000 Shares of HCW Biologics Inc. (NASDAQ:HCWB) Stock
americanbankingnews.com - May 27 at 6:58 AM
MarketBeat logoHCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam Purchases 33,450 Shares
americanbankingnews.com - May 26 at 6:38 AM
MarketBeat logoFinancial Comparison: HCW Biologics (HCWB) vs. Its Competitors
americanbankingnews.com - May 16 at 3:20 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and HCW Biologics (HCWB)
markets.businessinsider.com - May 10 at 7:54 PM
finance.yahoo.com logoHCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)
finance.yahoo.com - May 10 at 9:52 AM
marketwatch.com logo10-Q: HCW BIOLOGICS INC.
marketwatch.com - May 9 at 11:13 PM
msn.com logoRecap: HCW Biologics Q1 Earnings
msn.com - May 9 at 1:10 PM
msn.com logoHCW Biologics: Q1 Earnings Insights
msn.com - May 9 at 1:10 PM
finanznachrichten.de logoHCW Biologics, Inc: HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
finanznachrichten.de - May 9 at 8:10 AM
finance.yahoo.com logoHCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
finance.yahoo.com - May 9 at 8:10 AM
MarketBeat logoHCW Biologics (HCWB) and Its Rivals Critical Comparison
americanbankingnews.com - May 9 at 2:36 AM
finance.yahoo.com logoHCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
finance.yahoo.com - April 27 at 7:57 AM
MarketBeat logoEF Hutton Acquisition Co. I Reaffirms "Buy" Rating for HCW Biologics (NASDAQ:HCWB)
americanbankingnews.com - April 22 at 5:54 AM
MarketBeat logoHCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update
americanbankingnews.com - April 20 at 6:22 AM
msn.com logoEF Hutton Reiterates HCW Biologics (HCWB) Buy Recommendation
msn.com - April 19 at 6:39 PM
MarketBeat logoHCW Biologics (HCWB) versus Its Competitors Critical Analysis
americanbankingnews.com - April 17 at 9:06 AM
finance.yahoo.com logoHCW Biologics Poster Presentation at AACR Annual Meeting 2023
finance.yahoo.com - April 13 at 10:46 AM
finanznachrichten.de logoHCW Biologics, Inc: A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
finanznachrichten.de - April 5 at 3:13 PM
markets.businessinsider.com logoMaxim Group Remains a Buy on HCW Biologics (HCWB)
markets.businessinsider.com - April 5 at 10:12 AM
finance.yahoo.com logoA Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
finance.yahoo.com - April 3 at 10:12 AM
MarketBeat logoHCW Biologics' (HCWB) "Buy" Rating Reiterated at EF Hutton Acquisition Co. I
americanbankingnews.com - April 3 at 2:38 AM
markets.businessinsider.com logoHCW Biologics (HCWB) Receives a Buy from Maxim Group
markets.businessinsider.com - March 31 at 12:14 PM
finanznachrichten.de logoHCW Biologics, Inc: HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
finanznachrichten.de - March 29 at 7:29 PM
markets.businessinsider.com logoJonesTrading Reaffirms Their Buy Rating on HCW Biologics (HCWB)
markets.businessinsider.com - March 29 at 1:49 PM
msn.com logoLooking Into HCW Biologics's Return On Capital Employed
msn.com - March 29 at 1:49 PM
finance.yahoo.com logoHCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
finance.yahoo.com - March 28 at 6:05 PM
benzinga.com logoHCW Biologics Stock (NASDAQ:HCWB), Dividends
benzinga.com - March 26 at 8:22 AM
benzinga.com logoThe Global Biologics CDMO Market is forecast to grow by $13.26 bn during 2022-2027, accelerating at a CAGR of 13.97% during the forecast period
benzinga.com - March 1 at 7:04 PM
marketwatch.com logoWound Care Biologics Market Size 2023 with Top Significant Players, SWOT Analysis, End-User Industries and Segments Forecast 2029
marketwatch.com - February 19 at 10:31 PM
finance.yahoo.com logoBullish HCW Biologics Inc. (NASDAQ:HCWB) insiders filled their treasuries with US$687k worth of stock over last year
finance.yahoo.com - February 13 at 8:52 AM
finance.yahoo.com logoHCW Biologics (NASDAQ:HCWB) shareholders have endured a 18% loss from investing in the stock a year ago
finance.yahoo.com - January 3 at 12:31 PM
finance.yahoo.com logoHCW Biologics Enters CRADA with National Cancer Institute
finance.yahoo.com - December 8 at 6:29 PM
finance.yahoo.com logoHCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
finance.yahoo.com - December 7 at 8:58 AM
finance.yahoo.com logoHCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
finance.yahoo.com - December 7 at 8:58 AM
finance.yahoo.com logoHCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights
finance.yahoo.com - November 8 at 9:00 AM
finance.yahoo.com logoMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting
finance.yahoo.com - November 8 at 9:00 AM
yahoo.com logoSamsung Biologics obtains three global ISO certifications
yahoo.com - October 15 at 9:07 PM
nasdaq.com logoInvestors in HCW Biologics (NASDAQ:HCWB) have unfortunately lost 15% over the last year
nasdaq.com - October 15 at 10:15 AM
finance.yahoo.com logoHCW Biologics Inc. (HCWB)
finance.yahoo.com - September 23 at 6:20 PM
nasdaq.com logoTuesday 8/30 Insider Buying Report: HCWB, OSUR
nasdaq.com - August 30 at 5:10 PM
finance.yahoo.com logoTrade Alert: The Chief Financial Officer Of HCW Biologics Inc. (NASDAQ:HCWB), Rebecca Byam, Has Just Spent US$230k Buying 58% More Shares
finance.yahoo.com - August 28 at 1:11 PM
nasdaq.com logoHere's Why We're Not Too Worried About HCW Biologics' (NASDAQ:HCWB) Cash Burn Situation
nasdaq.com - August 17 at 6:43 PM
finance.yahoo.com logoHCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights
finance.yahoo.com - August 12 at 8:12 AM
finance.yahoo.com logoU.S. Patent Issued to HCW Biologics for Foundational Platform Technology
finance.yahoo.com - August 3 at 7:52 AM
finance.yahoo.com logoHCW Biologics (NASDAQ:HCWB) shareholders have endured a 57% loss from investing in the stock a year ago
finance.yahoo.com - July 27 at 10:36 AM
finance.yahoo.com logoHCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
finance.yahoo.com - May 23 at 8:18 AM
finance.yahoo.com logoHCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
finance.yahoo.com - May 23 at 8:18 AM
finance.yahoo.com logoHCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
finance.yahoo.com - May 13 at 6:01 PM
finance.yahoo.com logoHCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists
finance.yahoo.com - May 5 at 11:10 AM
stockhouse.com logoHCW Biologics' CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022
stockhouse.com - April 19 at 8:06 AM
Get HCW Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:HCWB) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -